Clinical Trials Browser

Terminated × Has results × Advanced Cancers × Clear all

NCT00836927 2019-02-18

MK-8669-038

Phase 2 Terminated

7 enrolled 13 charts

Advanced Cancers

NCT00877773 2016-08-25

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Phase 1/2 Terminated

44 enrolled 5 charts

Advanced Cancers